- 2020 (64) ▼
- 2019 (41) ▼
- 2018 (21) ▼
- 2017 (10) ▼
Pfizer Inc. (NYSE:PFE) and Protalix …
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has approved Cerdelga™ (eliglustat) capsules, the only first-line oral therapy for …
The European Medicines Agency (EMA) and the United States Food …
Together with the organising committee of the 11th EWGGD Meeting we are delighted to provide you with more information about the next meeting.
This year’s meeting will be held from June 25th to 28th, 2014 at the Dan Carmel Hotel in Haifa, …
FDA Grants Priority Review for Genzyme’s Cerdelga™ (eliglustat), an Investigational Oral Therapy for Gaucher Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company announced today that the Food and Drug Administration …
We are pleased to announce that ALAN a.s.b.l. (Association Luxembourgeoise d’aide pour les personnes atteintes de maladies neuromusculaires et de maladies rares) has joined the EGA as a full member.
The 10th anniversary of Slovenian Gaucher Association will be celebrated on 10th November 2013 in Ljubljana.
More information: email@example.com.
We are pleased to announce that Asociatia Pentru Boli Lizozomale Si Gaucher Din Republica Moldova, the Gaucher and Lysosomal Diseases Association of Moldova has joined the EGA as a full member.
There will be a whole host of presentations including: